Penza Veronica, Soriero Domenico, Sperotto Beatrice, Neri Alberto, Ortiz Jesus, Pertile Davide, Epis Lorenzo, Carganico Giacomo, Amisano Marco, Scabini Stefano, Caldwell Darwin G, Mattos Leonardo S
Advanced Robotics, Istituto Italiano di Tecnologia, 16163, Genoa, Italy.
Chirurgia Oncologica Ospedaliera, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy.
Sci Rep. 2025 May 15;15(1):16976. doi: 10.1038/s41598-025-00138-8.
Surgical safety has emerged as a significant public health concern. Ureteral injury (UI) is one of the most common forms of iatrogenic urological issues, lacking non-invasive prevention strategies. In this context, computer-assisted technologies offer a promising solution for enhancing intra-operative safety. This paper presents an in-vivo study focused on evaluating the feasibility of using an augmented reality (AR) surgical navigation system (EVA) for intra-operative ureteral identification on an animal model. An experienced surgeon performed a technical assessment of the system. The clinical evaluation was conducted by four general surgeons tasked with identifying the left or right ureter, both with and without EVA. The technical assessment highlighted that EVA is easily integrable with operating room instruments, achieving a calibration accuracy of [Formula: see text], and the virtual ureter effectively overlapping with the real ureter. The questionnaires indicated that surgeons appreciated EVA, with a [Formula: see text]. The perceived mental demand, task complexity, and distractions were lower when using the EVA system. Future work will focus on increasing the number of subjects and exploring the efficacy of the system on other clinical tasks.
手术安全已成为一个重大的公共卫生问题。输尿管损伤(UI)是医源性泌尿外科问题最常见的形式之一,缺乏非侵入性预防策略。在这种情况下,计算机辅助技术为提高术中安全性提供了一个有前景的解决方案。本文介绍了一项体内研究,重点评估在动物模型上使用增强现实(AR)手术导航系统(EVA)进行术中输尿管识别的可行性。一位经验丰富的外科医生对该系统进行了技术评估。由四名普通外科医生进行临床评估,他们的任务是在有和没有EVA的情况下识别左输尿管或右输尿管。技术评估强调,EVA很容易与手术室器械集成,校准精度达到[公式:见原文],虚拟输尿管与真实输尿管有效重叠。问卷调查表明,外科医生对EVA表示赞赏,赞赏率为[公式:见原文]。使用EVA系统时,感知到的心理需求、任务复杂性和干扰较低。未来的工作将集中在增加受试者数量,并探索该系统在其他临床任务上的疗效。